Description:

A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab,or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patientswith Untreated Metastatic Adenocarcinoma of the Colon or Rectum Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=37A89102-B023-3CED-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=37A89102-B023-3CED-E044-0003BA3F9857
Keywords:
  1. 12/18/14 12/18/14 - Martin Dugas
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 9/17/21 9/17/21 -
Uploaded on:

September 17, 2021

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00265850 Registration - CALGB 80405 REGISTRATION WORKSHEET - 2672321v1.0

No Instruction available.

  1. StudyEvent: CALGB 80405 REGISTRATION WORKSHEET
    1. No Instruction available.
Header Module
Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Ethnicity (Mark one)
Performance Status (ECOG/Zubrod scale)
cm
Kg
m2
Method of Payment
Race
Race
Certification Of Eligibility And Protocol Design
In the opinion of the investigator, is the patient eligible?
Planned protocol chemotherapy
Prior Adjuvant Chemotherapy
Prior Pelvic Radiation Therapy
Assigned Treatment Arm
Companion Studies
Did patient consent to take part in the Diet and Lifestyle Study
Consent given to contact patient for telephone interview
Patient's Initial Consent given for specimen kept for future use in research to learn about, prevent, or treat cancer
Patient's initial consent given for specimen(s) may be kept for use in research to learn about, prevent, or treat other health problems (for example: diabetes, Alzheimer's disease, or heart disease)
Patient's initial consent given for further contact regarding specimen?
Patient's initial consent given for blood specimen use for genetic research on patient's cancer?
Registration Information

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial